Insulin sensivitiy, $beta$ cell function and serum lipid levels in Helicobacter pylori positive, non-obese, young adult males

Insulin sensivitiy, $beta$ cell function and serum lipid levels in Helicobacter pylori positive, non-obese, young adult males

It is not clear whether Helicobacter pylori (Hp) infection affects insulin levels and insulin sensitivity. We aimed to determine insulin sensitivity and beta cell function, and to evaluate serum lipids in subjects with and without Hp infection. Eighty non-obese young adult males, 40 of whom were Hp positive and 40 were negative, were included in the study. Two endoscopic biopsy specimens were obtained from each subject. Height, weight and waist-hip circumference were measured, and body mass index (BMI) was calculated. Serum glucose, total, HDL, LDL and VLDL-cholesterol and triglyceride levels were determined. Body fat mass and percentage were determined by bioelectric impedance. Serum insulin levels were measured by the RIA method. HOMA was used as an index of pancreatic beta cell function and insulin sensitivity. The independent-t test was used in the comparison of results. Age, BMI, waist and hip circumferences, and fat percentages did not exhibit any statistical differences. Mean HOMA-B [111.7, in Hp(+) and 112.0 in Hp(-) subjects] and HOMA-S [67.7 in Hp(+) and 60.7 Hp(-) subjects] did not differ amoung the groups. The lipid and aminotransferase levels of the 2 groups were also similar. Conclusion: Hp infection is not associated with impairment of insulin sensitivity and deterioration of the glucose metabolism. It seems to be metabolically neutral in terms of serum lipids and aminotransferase levels.

___

  • 1. Anastasios R, Goritsas C, Papamihail C. et al. Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings. Eur J Intern Med 13: 376, 2002.
  • 2. Leontiadis GI, Sharma VK, Howden CW. Non-gastrointestinal tract associations of Helicobacter pylori infection. Arch Intern Med 159: 925-40, 1999.
  • 3. Ko GT, Chan FK, Chan WB. Helicobacter pylori infection in Chinese subjects with type 2 diabetes. Endocr Res 27: 171-7, 2001.
  • 4. Xia HH, Talley NJ, Kam EP. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 96: 1039-46, 2001.
  • 5. Marrollo M, Latella G, Melideo D. Increased prevalence of Helicobacter pylori in patients with diabetes mellitus. Dig Liver Dis 33: 21-9, 2001.
  • 6. Scragg RK, Fraser A, Metcalf PA. Helicobacter pylori seropositivity and cardiovascular risk factors in a multicultural workforce. J Epidem. Community Health 50: 578-9, 1996.
  • 7. McDonagh TA, Woodward M, Morrison CE. et al. Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur Heart J 18: 1257-60, 1997.
  • 8. Martin-de-Argila C, Boixeda D, Canton R. High seroprevalence of Helicobacter pylori infection in coronary heart disease. Lancet 346(8970): 310, 1995.
  • 9. Peach HG, Barnett NE. Helicobacter pylori infection and fasting plasma glucose concentration. J Clin Pathol 54: 466-9, 2001.
  • 10. Matthews DR, Hosker JP, Rudenski AS. Homeostasis model assessment: insulin resitance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-9, 1985.
  • 11. Turner RC, Holman RR, Matthews D. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism. 1979 Nov;28(11):1086-96.
  • 12. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214-23.
  • 13. Steppan CM, Bailey ST, Bhat S. The hormone resistin links obesity to diabetes. Nature 409: 307Ð12, 2001.
  • 14. Escalante Pulido JM, Alpizar Salazar M. Changes in insulin sensitivity, secretion and glucose effectiveness during menstrual cycle. Arch Med Res 30: 19-22, 1999.
  • 15. Ryan AS, Nicklas BJ, Berman DM. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women. Diabetes Care 25: 127-33, 2002.
  • 16. Yates AP, Laing I. Age-related increase in hemoglobin A1c and fasting plasma glucose is accompanied by a decrease in beta cell function without change in insulin sensitivity: evidence from a cross-sectional study of hospital personnel. Diabet Med. 19: 254- 8, 2002.
  • 17. Elahi D, Muller DC, Egan JM. Glucose tolerance, glucose utilization and insulin secretion in ageing. Novartis Found Symp 242: 222-42, 2002.
  • 18. Larsen MO, Rolin B, Wilken M. Parameters of glucose and lipid metabolism in the male Gottingen minipig:influence of age, body weight, and breeding family. Comp Med 51: 436-42, 2001.